Agilis is a biotechnology company that engages in developing gene-based therapeutics for rare monogenic diseases that affect the central nervous system... Read more
Agilis is a biotechnology company that engages in developing gene-based therapeutics for rare monogenic diseases that affect the central nervous system... Read more
News
Aug 24, 2018
BioPortfolio
Agilis Biotherapeutics: PTC Therapeutics Successfully Completes Acquisition of Agilis Biotherapeutics
Jul 19, 2018
Investor’s Business Daily
Agilis Biotherapeutics: Biotech With 'Superstar' Drug Also Plans To Buy Gene Therapy Firm
May 16, 2018
BioPortfolio
Agilis Biotherapeutics: Agilis Biotherapeutics Conducts a Scientific Symposium for Education and Awareness of AADC Deficiency at the 21st Annual Meeting of the American Society of Gene & Cell Therapy ASGCT
May 02, 2018
4-traders
Agilis Biotherapeutics: Agilis Biotherapeutics Presents on Gene Therapy Pricing Strategies at the 2nd Annual Gene Therapy for Rare Disorders Summit
Jan 05, 2018
PharmiWeb
Agilis Biotherapeutics: Agilis Biotherapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
Jan 05, 2018
StreetInsider
Press Release: Agilis Biotherapeutics : Agilis Biotherapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
Dec 13, 2017
Banker & Tradesman
Agilis Biotherapeutics: Two Cambridge Firms Relocating To Lynnfield Complex
Dec 06, 2017
Military Technologies News
Agilis Biotherapeutics: Latest Research on Smart Drug Delivery System Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, 2017 To 2022, Focusing On Top Key Vendors: 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis Biotherapeutics LLC, Aileron Therapeutics Inc
Oct 31, 2017
BioPortfolio
Agilis Biotherapeutics: Agilis Biotherapeutics Announces Orphan Product Designation Approval in Europe for the Treatment of Friedreich Ataxia
Oct 20, 2017
PharmiWeb
Agilis Biotherapeutics: Agilis Biotherapeutics Announces Presentations on Angelman Syndrome Program at ESGCT and NORD Rare Disease Summit
Agilis Biotherapeutics Competitors
1
2
3
4
5
6
7
8
9
10